Orthobiologics are substances, found in human body, used for faster healing process of injuries such as, broken bones, injured muscles, and ligaments. These substances are made up of substances found in human body. When orthobiologics are used in higher concentration, they help in accelerating healing process. The faster recovery process, reduction in number hospital visits, and accelerated healing are the benefits due to which orthobiologics are gaining prominence.
The key factors driving the growth of the global orthobiologics market are increase in road accidents & sports injuries, rise in obesity rate, awareness among patients & athletes, and rapidly aging population. However, high cost of procedures, stringent regulatory approval procedures for each of the orthobiologic products, and lack of reliable clinical trial data are factors restraining the growth of this market. Advancements in implant technologies and growing demand of biological solutions as compared to mechanical solution create opportunities for its growth.
The global orthobiologics market is segmented based on product, end user, and geography. The market is further classified based on product into bone allograft, stem cell therapy, bone graft substitutes, bone growth factors & spinal stimulation, and viscosupplementation. On the basis of end user, the market is further categorized into hospitals, orthopedic clinics, and others. The market segmented geographically into North America, Europe, Asia, and Rest of the World (RoW).
The key manufacturers profiled in the report are Biomet Inc., Stryker Corporation, Medtronic PLC., Integra Life Sciences Corporation, Zimmer Inc., DePuy Synthes, Exactech Inc., Tornier Inc., Globus Medical Inc., Nuvasive Inc., and Wright Medical Technology Inc. The manufacturers implement strategies, such as agreements, partnerships, mergers & acquisitions, and others to gain the prominence in the market.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
SIMILAR MARKET STUDIES
Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, and Services), Technology (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), Application (Robot-assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), and End User (Healthcare Provider, Pharmaceutical & Biotechnology Company, Patient, and Payer) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Artificial intelligence assists the machines to perform any task without human interventions. It uses different algorithms and software that help the machine to inculcate perception and reasoning for various situations. AI is widely applicable in the healthcare sector for various purposes such as drug discovery and precision medicine. In addition, ...
July 2017 | $5370 | View Details >>
The Global Ursodeoxycholic Acid market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Ursodeoxycholic Acid in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and ...
July 2017 | $4960 | View Details >>
The Ursodeoxycholic Acid market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include ICE Grindeks ...
July 2017 | $3360 | View Details >>
The Global Ursodeoxycholic Acid market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Ursodeoxycholic Acid in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, ...
July 2017 | $4960 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research